GLP-1-Based Therapeutics Summit
May 15 - 16, 2024 - PA USHanson Wade
info@hansonwade.com
Phone:0000000000
Welcome to the Inaugural GLP-1-Based Therapeutics Summit! - Elucidate Strategies for Product Specialization and Indication Expansion through Pharmacoeconomic Analysis Grab your copy of the Full Agenda: https://ter.li/jphri4 Amidst the resounding success of Novo's SELECT trial, the clinical trial landscape finds itself inundated with a surge of innovative GLP-1 treatments. Each passing week witnesses the unveiling of new multi-million-dollar investments, propelling GLP-1 players to the forefront of pharmaceutical revenue growth. Uniting the industry decision-makers behind the explosion of GLP-1 assets, the GLP-1-Based Therapeutics Summit stands as a pivotal platform. Uniquely positioned, it serves as the nexus for industry decision-makers, providing invaluable insights to guide therapeutic strategies, enabling the development of the right drugs for patients at the right price. Built with insights from industry giants including Eli Lilly, Novo Nordisk, Amgen, Carmot Therapeutics, Altimmune, and Pfizer, join 80+ industry leaders in Product Planning, Clinical Development, Medical Research, and Commercial Strategy. If you are looking to differentiate your GLP-1 products, stand out in the market, or discover the newest innovations in improving tolerability, efficacy, and durability of GLP-1s, there has never been a more appropriate time to unite and navigate this exploding field! Register now for exclusive savings and additional group discounts: https://ter.li/b5fj5s Time: 7:45 AM - 4:15 PM